Notification of Interim Results
RNS Number : 8119O
Immupharma PLC
23 September 2011
|
For Immediate Release |
23 September 2011 |
ImmuPharma PLC
Notification of Interim Results
Date: 30 September 2011
ImmuPharma PLC (AIM:IMM), the specialist discovery and development pharmaceutical company, is scheduled to announce its Interim Results for the six months ended 30 June 2011 on 30 September 2011.
- Ends -
For further information, please contact:
|
ImmuPharma PLC |
|
|
Dr Robert Zimmer, President |
+33 389 66 13 20 |
|
Richard Warr, Chairman |
+44 20 7152 4080 |
|
Dimitri Dimitriou, Chief Executive Officer |
+44 20 7152 4080 |
|
|
|
|
|
|
|
Buchanan Communications |
+ 44 20 7466 5000 |
|
Lisa Baderoon, Mark Court |
|
|
|
|
|
Panmure Gordon & Co |
+44 151 243 0963 |
|
Andrew Burnett |
|
|
|
|
|
Espirito Santo Investment Bank |
+44 20 7456 9191 |
|
James Bromhead, Richard Crawley |
|
This information is provided by RNS
The company news service from the London Stock Exchange
Latest directors dealings
- 1 day ago The Renewables Infrastructure Group Limited
- 1 day ago The Renewables Infrastructure Group Limited
- 1 day ago Smurfit Westrock (DI)
- 1 day ago Menhaden Resource Efficiency
- 1 day ago BP